Integrated Community Engagement and Audit Systems
Launched by AGA KHAN UNIVERSITY · Nov 28, 2022
Trial Information
Current as of January 16, 2025
Enrolling by invitation
Keywords
ClinConnect Summary
Background:
Previous Efforts at Introducing Audit Systems in Pakistan Previous efforts to introduce facility Audit Systems with the support of WHO and other government initiatives have been undertaken. The Ministry of National Health Services, Regulations and Coordination, Government of Pakistan published national protocols with detailed operational guidelines, protocols, training materials, tools on phased implementation of the Maternal \& Perinatal Death Surveillance and Response (MPDSR) to enhance reporting, recording, tracking, and auditing of deaths. Implementation of the protocols at...
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Married women aged 15-49 years
- • Children Under five years of age
- Exclusion Criteria:
- • • Women who are non- residents of the study district and who do not provide consent.
Trial Officials
Zulfiqar Bhutta, PhD
Principal Investigator
The Aga Khan University
About Aga Khan University
Aga Khan University (AKU) is a distinguished institution dedicated to improving health and education across developing regions. Established in 1983, AKU is recognized for its commitment to research excellence, particularly in clinical trials that address pressing health issues in diverse populations. With a focus on advancing medical knowledge and practice, AKU's clinical trial initiatives are designed to foster innovative solutions and enhance patient care. The university collaborates with various local and international partners, leveraging its multidisciplinary expertise to conduct rigorous research that informs public health policy and improves health outcomes in communities served by its facilities.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Karachi, Sindh, Pakistan
People applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Discussion 0
Similar Trials